Meeting details

VERTEX PHARMACEUTICALS INCORPORATED



Proposal 1A.
Election of Director: Sangeeta Bhatia

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 1B.
Election of Director: Lloyd Carney

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 1C.
Election of Director: Alan Garber

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 1D.
Election of Director: Terrence Kearney

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 1E.
Election of Director: Reshma Kewalramani

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 1F.
Election of Director: Yuchun Lee

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 1G.
Election of Director: Jeffrey Leiden

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 1H.
Election of Director: Margaret McGlynn

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 1I.
Election of Director: Diana McKenzie

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 1J.
Election of Director: Bruce Sachs

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 1K.
Election of Director: Suketu Upadhyay

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 2.
Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2022.

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 3.
Advisory vote to approve named executive office compensation.

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 4.
Approval of an amendment and restatement of our 2013 Stock and Option Plan to increase the number of shares authorized for issuance under this plan by 13.5 million shares.

Caisse vote:
Against

Applicable policy or principle:
PC_00

See all shareholders' meetings for this company